Portal de Periódicos da CAPES

Spurious and counterfeit drugs: a growing industry in the developing world

2009; Oxford University Press; Volume: 85; Issue: 1003 Linguagem: Inglês

10.1136/pgmj.2008.073213

1469-0756

C S Gautam, A Utreja, Girdhari Lal Singal,

Intellectual Property and Patents

Abstract Spread of spurious/counterfeit/substandard drugs is a modern day menace which has been recognised internationally, especially so in developing countries. The problem assumes added significance in view of rapid globalisation. The market of spurious and counterfeit drugs is a well-organised, white collar crime. Poverty, high cost of medicines, lack of an official supply chain, legislative lacunae, easy accessibility to computerised printing technology, ineffective law enforcement machinery, and light penalties provide the counterfeiters with an enormous economic incentive without much risk. The consequences of the use of such medicines may vary from therapeutic failure to the occurrence of serious adverse events and even death. Proper drug quality monitoring, enforcement of laws and legislation, an effective and efficient regulatory environment, and awareness and vigilance on part of all stakeholders can help tackle this problem.